Kishi Kasei Co., Ltd. (President: Daisuke Maezawa) and SPERA PHARMA, Inc. (President: Toshio Yoshioka) have agreed to a business collaboration combining Kishi Kasei’s contract manufacturing of Biomaterials and...
News
- HOME
- News
At the 4th International Symposium for Medicinal Sciences held on March 27, at Kanazawa Art Hall/Kanazawa Motenashi Dome during the 138th Annual Meeting of The Pharmaceutical Society of Japan (March 25 - 28), ...
At The 12th Process Chemistry Lounge, held at the Yugawara Traning Center of Wako Pure Chemical Industries, Ltd., on December 1 - 2, 2017, Kazuki Azuma of Chemical R&D Division gave a lecture on "Development o...
At the 2017 Winter Symposium of the Japanese Society of Process Chemistry held in Nagasaki city on December 8, 2017, the JSPC Award Ceremony was held for the awardees selected at the 2017 Summer Symposium. Say...
An article on API process research in the Chemical R&D Division of the company has been published and is described by one of the authors, Dr. Ikemoto. http://pubs.acs.org/doi/10.1021/acs.oprd.7b00313 Title: ...
SPERA PHARMA exhibited a company's booth at The 38th Annual Scientific Meeting of the Japanese Society of Clinical Pharmacology and Therapeutics, which was held for three days from December 7, 2017 at PACIFIC...
MORE
page top